POS apart from FDA approvals can we explore other possible near term triggers for upwards SP movement.
- the June financial report results which should show a lift in sales in nations other than the US, due soon (already cash flow positive)
- annual report and AGM which will show strategy, and possible press releases to feed into
- publicity, and possible analyst reports which link with US stock listing.
The macro setting, with the stock market still looking shaky, could well favour AVH with investors looking for recession-proof safe haven stock, as in health sector. This might feed into to good analyst reports as a good news story.
At any rate, it's all coming together for LT holders...another 6 months or 12 months for the big lift off won't bother me.
cheers
DV
us demand, page-22
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.70 |
Change
0.060(2.27%) |
Mkt cap ! $187.0M | |||
| Open | High | Low | Value | Volume |
| $2.71 | $2.73 | $2.67 | $220.7K | 81.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $2.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.70 | 418 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |